AARTI DRUGS LTD. - 524348 - Shareholding for the Period Ended October 01, 2020
Aarti Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended October 01, 2020. For more details, kindly Click here06-10-2020
AARTI DRUGS LTD. - 524348 - Shareholding for the Period Ended October 01, 2020
Aarti Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended October 01, 2020. For more details, kindly Click hereAARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Allotment
In continuation of our intimation on outcome of the Board Meeting held on August 20, 2020 pertaining to recommendation of Issue of Bonus Shares, and subsequent to the approval of shareholders accorded through Postal Ballot on September 20, 2020, the Allotment Committee of the Board of Directors through circular resolution passed today i.e October 5, 2020 approved the allotment of 6,99,00,000 (Six Crore Ninety Nine lakhs) Equity Shares of Rs. 10/- each as fully paid up, in the ratio of 3:1, to the eligible members whose name appear in the register of members/ list of beneficial owners as on October 1, 2020, being the record date fixed for this purpose.AARTI DRUGS LTD. - 524348 - Clarification sought from Aarti Drugs Ltd
The Exchange has sought clarification from Aarti Drugs Ltd on October 5, 2020, with reference to Movement in Price.The reply is awaited.AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we inform you that the Company has received information from Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company for Loss of share certificatesAARTI DRUGS LTD. - 524348 - Closure of Trading Window
This is to inform that the Trading Window of the Company will remain closed from Thursday, October 1, 2020 until the expiry of 48 hours after the declaration of Financial Results of the Company for the quarter and half year ended September 30, 2020.AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the Company has received information from Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company for Loss of share certificatesAARTI DRUGS LTD. - 524348 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Aarti Drugs Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click hereAARTI DRUGS LTD. - 524348 - Record Date For Issue Of Bonus Shares
In continuation of our intimation on outcome of Board Meeting held on August 20, 2020 pertaining to the recommendation of issue of Bonus Shares in the Ratio of 3:1 i.e. 3 (Three) Bonus Equity Share of Rs. 10/- each for 1 (One) fully paid up Equity Share of Rs. 10/- each, and subsequent to the approval of shareholders through Postal Ballot, the Company has fixed Thursday, October 1, 2020 as the 'Record Date' to determine the eligible shareholders entitled to receive the Bonus Shares.AARTI DRUGS LTD. - 524348 - Voting Result Of Postal Ballot
In accordance with the Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Voting Results and Scrutinizer's Report for the resolutions for increase in the Authorised Share Capital and issue of Bonus Shares, as set out in the Postal Ballot Notice dated August 20, 2020.AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the Company has received information from Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company for Loss of share certificates